Abstract
Exosomes are ubiquitous nanovesicles considered as biological body language. They are deeply involved in prostate cancer (PC), from its initiation until angiogenesis, and metastasis. Recent studies sensed the crucial value of exosomes and could imagine the important link between those nanoparticles, enhancing the diagnosis and treatments against PC. Although the emperical level of studies achieved until today, pore data have been collected about exosome’s mechanistic in PC. Therefore, through this review, we would like to shed light on the recent knowledge of the role of exosomes in PC and the recent applications of exosomes in enhancing the efficacities of diagnosis and therapies to beat PC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AS:
-
Androgen signaling
- CSCs:
-
Cancer stem cells
- PC:
-
Prostate cancer
- PCSCSs:
-
Prostate cancer stem cells
- SCs:
-
Stem cells
References
Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E et al (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14:677–685
Caradec J, Kharmate G, Hosseini-Beheshti E, Adomat H, Gleave M, Guns E (2014) Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem 47:1286–1292
Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D et al (2010) Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Investig 120:457–471
Chen CM, Huang YS, Fang PW, Liang CW, Chang RF (2019) A computer-aided diagnosis system for differentiation and delineation of malignant regions on whole-slide prostate histopathology image using spatial statistics and multidimensional DenseNet. Med Phys 47(3):1021–1033
Cheng Y, Zeng Q, Han Q, Xia W (2019) Effect of pH, temperature and freezing-thawing on quantity changes and cellular uptake of exosomes. Protein Cell 10:295–299
Dong Soo Lee MS, Kang SY, Hwang DW (2019) Physiologic constraints of using exosomes in vivo as systemic delivery vehicles. Prec Nanomed 2:344–369
Drake RR, Kislinger T (2014) The proteomics of prostate cancer exosomes. Expert Rev Proteomics 11:167–177
Eggener SE, Rumble RB, Armstrong AJ, Morgan TM, Crispino T, Cornford P, van der Kwast T, Grignon DJ, Rai AJ, Agarwal N et al (2019) Molecular biomarkers in localized prostate cancer: ASCO guideline. J Clin Oncol 38(13):1474–1494
Erdal Karaoz ES, Demir CS (2019) Mesenchymal stem cell-derived exosomes do not promote the proliferation of cancer cells in vitro. Int J Physiol Pathophysiol Pharmacol 11:177–189
Foote JR, Patel AA, Yona S, Segal AW (2019) Variations in the phagosomal environment of human neutrophils and mononuclear phagocyte subsets. Front Immunol 10:188
He YF, Hooker E, Yu EJ, Cunha GR, Liao L, Xu JM, Earl A, Wu HQ, Gonzalgo ML, Sun ZJ (2019) Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells. Oncogene 38:2337–2350
Heiden MGV, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Horton C, Liu Y, Yu C, Xie Q, Wang ZA (2019) Luminal-contact-inhibition of epithelial basal stem cell multipotency in prostate organogenesis and homeostasis. Biol Open 8:bio045724
Huang XY, Yuan TZ, Liang MH, Du MJ, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F et al (2015) Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol 67:33–41
Ill-Min Chunga GR, Venkidasamyb B, Subramanianc U, Thiruvengadam M (2020) Exosomes: current use and future applications. Clin Chim Acta 500:226–232
Jalalian SH, Ramezani M, Jalalian SA, Abnous K, Taghdisi SM (2019) Exosomes, new biomarkers in early cancer detection. Anal Biochem 571:1–13
Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M (2014) A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 1846:75–87
Kalluri R (2016) The biology and function of exosomes in cancer. J Clin Invest 126:1208–1215
Karthaus WR, Sawyers CL (2019) Strategies to identify and target cells of origin in prostate cancer. J Natl Cancer Inst 111:221–223
Kato T, Mizutani K, Kameyama K, Kawakami K, Fujita Y, Nakane K, Kanimoto Y, Ehara H, Ito H, Seishima M et al (2015) Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer. Urol Oncol 33:385.e15-20
Kawakami K, Fujita Y, Kato T, Mizutani K, Kameyama K, Tsumoto H, Miura Y, Deguchi T, Ito M (2015) Integrin beta4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance. Int J Oncol 47:384–390
Kumar D, Gupta D, Shankar S, Srivastava RK (2015) Biomolecular characterization of exosomes released from cancer stem cells: possible implications for biomarker and treatment of cancer. Oncotarget 6:3280–3291
Li FXZ, Liu JJ, Xu F, Lin X, Zhong JY, Wu F, Yuan LQ (2019) Role of tumor-derived exosomes in bone metastasis. Oncol Lett 18:3935–3945
Li H, Kim C, Liu W, Zhu J, Chin K, Rodriguez-Canales J, Rodgers GP (2020) Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Int J Cancer 146:1346–1358
Liang GF, Zhu YL, Ali DJ, Tian T, Xu HT, Si K, Sun B, Chen BA, Xiao ZD (2020) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol 18:10
Lin W, Huang L, Li Y, Fang B, Li G, Chen L, Xu L (2019) Mesenchymal stem cells and cancer: clinical challenges and opportunities. Biomed Res Int 2019:2820853
Lin Y, Lu Y, Li X (2020) Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target 28:129–141
Logozzi M, Capasso C, Di Raimo R, Del Prete S, Mizzoni D, Falchi M, Supuran CT, Fais S (2019) Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem 34:272–278
Lorenc T, Klimczyk K, Michalczewska I, Slomka M, Kubiak-Tomaszewska G, Olejarz W (2020) Exosomes in prostate cancer diagnosis, prognosis and therapy. Int J Mol Sci 21:2118
Mariantonia Logozzia DM, Capassob C, Del Preteb S, Di Raimoa R, Falchic M, Angelinid DF, Sciarrae A, Maggie M, Supuranf CT, Faisa S (2020) Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH. J Enzyme Inhib Med Chem 35(1):280–288
Martins VR, Dias MS, Hainaut P (2013) Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 25:66–75
Mei W, Lin X, Kapoor A, Gu Y, Zhao K, Tang D (2019) The contributions of prostate cancer stem cells in prostate cancer initiation and metastasis. Cancers (Basel) 11:434
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N et al (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177–182
Minciacchi VR, Zijlstra A, Rubin MA, Di Vizio D (2017) Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? Prostate Cancer Prostatic Dis 20:251–258
Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP, Strobel T, Breakefield XO, Saydam O (2013) Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 21:101–108
Overbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A (2015) Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget 6:30357–30376
Rodriguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Line A, Llorente A (2017) Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer 16:156
Sahebi R, Langari H, Fathinezhad Z, Sani ZB, Avan A, Mobarhan MG, Rezayi M (2020) Exosomes: new insights into cancer mechanisms. J Cell Biochem 121:7–16
Sento S, Sasabe E, Yamamoto T (2016) Application of a persistent heparin treatment inhibits the malignant potential of oral squamous carcinoma cells induced by tumor cell-derived exosomes. Plos One 11:e0148454
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30
Simpson RJ, Lim JW, Moritz RL, Mathivanan S (2009) Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 6:267–283
Skvortsov S, Skvortsova II, Tang DG, Dubrovska A (2018) Concise review: prostate cancer stem cells: current understanding. Stem Cells 36:1457–1474
Staicu CE, Predescu D-V, Rusu CM, Radu BM, Cretoiu D, Suciu N, Crețoiu SM, Voinea S-C (2020) Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview. Cell 9:169
Tai YL, Chu PY, Lee BH, Chen KC, Yang CY, Kuo WH, Shen TL (2019) Basics and applications of tumor-derived extracellular vesicles. J Biomed Sci 26:35
Takahashi A, Okada R, Nagao K, Kawamata Y, Hanyu A, Yoshimoto S, Takasugi M, Watanabe S, Kanemaki MT, Obuse C et al (2017) Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun 8:15287
Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP (2015) Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 12:445–464
Tian YH, Li SP, Song J, Ji TJ, Zhu MT, Anderson GJ, Wei JY, Nie GJ (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–2390
Tsai KS, Yang SH, Lei YP, Tsai CC, Chen HW, Hsu CY, Chen LL, Wang HW, Miller SA, Chiou SH et al (2011) Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141:1046–1056
Vlaeminck-Guillem V (2018) Extracellular vesicles in prostate cancer carcinogenesis, diagnosis, and management. Front Oncol 8:222
Wang Y, Hayward S, Cao M, Thayer K, Cunha G (2001) Cell differentiation lineage in the prostate. Differentiation 68:270–279
Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, Wymant J, Jones AT, Kynaston H, Mason MD et al (2015) Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene 34:319–331
Wu J, Qu Z, Fei ZW, Wu JH, Jiang CP (2017) Role of stem cell-derived exosomes in cancer. Oncol Lett 13:2855–2866
Wu MW, Wang GS, Hu WL, Yao YH, Yu XF (2019) Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol Cancer 18:53
Xin L (2019) Cells of origin for prostate cancer. Adv Exp Med Biol 1210:67–86
Ye L-F, He S, Wu X, Jiang S, Zhang R-C, Yang Z-S, Chen F-W, Pan D-L, Li D, Li G (2020) Detection of prostate cancer antigen 3 and prostate cancer susceptibility candidate in non-DRE urine improves diagnosis of prostate cancer in Chinese population. Prostate Cancer 2020:3964615
Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G (2013) Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther 4:70
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W (2015) Exosomes in cancer: small particle, big player. J Hematol Oncol 8:83
Zomer A, Maynard C, Verweij FJ, Kamermans A, Schafer R, Beerling E, Schiffelers RM, de Wit E, Berenguer J, Ellenbroek SIJ et al (2015) In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161:1046–1057
Acknowledgment
Funding: no financial support was received to achieve this work.
Disclosure of interests: The author declares no conflict of interest with this work. This article does not contain any studies with human participants performed by the author. This article does not contain any studies with animals performed by the author.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Moulay, M., Al-Kareem, S. (2021). Exosomes: The Crucial Element in Prostate Cancer. In: Alzahrani, F.A., Saadeldin, I.M. (eds) Role of Exosomes in Biological Communication Systems. Springer, Singapore. https://doi.org/10.1007/978-981-15-6599-1_15
Download citation
DOI: https://doi.org/10.1007/978-981-15-6599-1_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6598-4
Online ISBN: 978-981-15-6599-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)